Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002-2014.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  American Journal of Preventive Medicine

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amepre.2016.02.014PMID 27079639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug poisoning deaths in the United States, 1999–2012: a statistical adjustment analysis

  2016cited by this paper
• OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality

  2016cited by this paper
• OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality

  2016cited by this paper
• Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study

  2015cited by this paper
• Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines.

  2015cited by this paper
• Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access.

  2015cited by this paper
• National Institutes of Health Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain

  2015cited by this paper
• Impact of the Combined Use of Benzodiazepines and Opioids on Workers' Compensation Claim Cost

  2014cited by this paper
• Vital Signs: Variation Among States in Prescribing of Opioid Pain Relievers and Benzodiazepines — United States, 2012

  2014cited by this paper
• Benzodiazepines

  2014cited by this paper
• (260) Trends in benzodiazepine prescription and co-prescription with opioids in primary care clinics in the United States, 2002 to 2009

  2014cited by this paper
• Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011.

  2014cited by this paper
• Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.

  2014cited by this paper
• Risk of Adverse Health Outcomes with Increasing Duration and Regularity of Opioid Therapy

  2014cited by this paper
• GPs' management strategies for patients with insomnia: a survey and qualitative interview study.

  2014cited by this paper
• Comparison of toxicity associated with nonmedical use of benzodiazepines with buprenorphine or methadone.

  2014cited by this paper
• Pharmaceutical overdose deaths, United States, 2010.

  2013cited by this paper
• Doctor and Pharmacy Shopping for Controlled Substances

  2013cited by this paper
• National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009.

  2013cited by this paper
• Benzodiazepines in long-term opioid therapy.

  2013cited by this paper
• Prescription Drug Monitoring Programs, a Response to Doctor Shopping: Purpose, Effectiveness, and Directions for Future Research

  2012cited by this paper
• Doctor shopping: a phenomenon of many themes.

  2012cited by this paper
• American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

  2012cited by this paper
• Potential Impact of Benzodiazepine Use on the Rate of Hip Fractures in Five Large European Countries and the United States

  2012cited by this paper
• American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

  2012cited by this paper
• Concomitant medication among persistent opioid users with chronic non‐malignant pain

  2012cited by this paper
• Polydrug abuse: a review of opioid and benzodiazepine combination use.

  2012cited by this paper
• American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.

  2012cited by this paper
• Doctor and Pharmacy Shopping for Controlled Substances

  2012cited by this paper
• Group Health's initiative to avert opioid misuse and overdose among patients with chronic noncancer pain.

  2011cited by this paper
• Drug poisoning deaths in the United States, 1980-2008.

  2011cited by this paper
• Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.

  2011cited by this paper
• Opioid dose and drug-related mortality in patients with nonmalignant pain.

  2011cited by this paper
• Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness.

  2011cited by this paper
• Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.

  2011cited by this paper
• Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain

  2010cited by this paper
• Opioid Prescriptions for Chronic Pain and Overdose

  2010cited by this paper
• Usefulness of prescription monitoring programs for surveillance—analysis of Schedule II opioid prescription data in Massachusetts, 1996–2006

  2010cited by this paper
• Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004-2008.

  2010cited by this paper
• Emergency Department Visits Involving Nonmedical Use of Selected Prescription Drugs in the United States, 2004–2008

  2010cited by this paper
• Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006.

  2009cited by this paper
• Opioids and the control of respiration.

  2008cited by this paper
• Physicians’ Perspectives on Prescribing Benzodiazepines for Older Adults: A Qualitative Study

  2007cited by this paper
• Prescription drug monitoring programs.

  2006cited by this paper
• Abuse of prescription drugs and the risk of addiction.

  2006cited by this paper
• One hundred seventy two deaths involving the use of oxycodone in Palm Beach County.

  2005cited by this paper
• Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions.

  2004cited by this paper
• Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions.

  2004cited by this paper
• Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

  2003cited by this paper
• Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases.

  2003cited by this paper
• National Patterns of Medication Treatment for Depression, 1987 to 2001.

  2001cited by this paper
• Mechanisms of fatal opioid overdose.

  1999cited by this paper
• Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties.

  1998cited by this paper
• Benzodiazepines revisited.

  1998cited by this paper
• Defining inappropriate practices in prescribing for elderly people: a national consensus panel.

  1997cited by this paper
• Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

  1994cited by this paper
• Benzodiazepine dependence, toxicity, and abuse: A task force report of the American Psychiatric Association published by American Psychiatric Press Washington, DC 1990, 116 pages, $25.00

  1992cited by this paper
• Guidelines for prescribing psychoactive drugs in the elderly: Part 1.

  1991cited by this paper

• Factors Associated with Benzodiazepine Misuse Among Those Who Misused Opioids Within the Past Year: A U.S. National Analysis

  2025cites this paper
• Trends in Drug Claims for Non‐Specific Low Back Pain in Québec, 1997 to 2018

  2025cites this paper
• Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer.

  2025cites this paper
• Effect of midazolam co-administered with oxycodone on ventilation: a randomised clinical trial in healthy volunteers

  2025cites this paper
• Concomitant use of prescription opioids and psychotropic medications: analysis of Mississippi Medicaid members.

  2025cites this paper
• Early detection of patients with narcotic use disorder using a modified morphine equivalent daily dose score based on an analysis of real-world prescription patterns: a retrospective cohort study

  2024cites this paper
• Clinical characteristics of substance use disorders elderly patients: A look at a Swiss psychogeriatric inpatient unit

  2024cites this paper
• Benzodiazepine Adverse Reaction Cases Age 50 and Older Reported to the U.S. Poison Centers: Healthcare Use and Major Medical Effects

  2024cites this paper
• Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study

  2024influential citation
• The Effect of Veteran Status and Chronic Pain on Past 30-Day Sedative Use Among Community-Dwelling Adult Males

  2024cites this paper
• The effect of combat deployments on veteran opioid abuse.

  2024cites this paper
• Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999–2018

  2024cites this paper
• Trends in naloxone co-prescriptions.

  2024cites this paper
• Sedative-hypnotic Co-prescribing with Opioids in a Large Network of Community Health Centers

  2023cites this paper
• Trends in co-prescribed opioids and benzodiazepines, non-prescribed opioids and benzodiazepines, and schedule-I drugs in the United States, 2013 to 2019

  2023cites this paper
• Concurrent opioid and alcohol withdrawal management

  2023cites this paper
• Directive clinique no 443a : Opioïdes aux différentes étapes de la vie des femmes : Fertilité, contraception, douleur chronique et ménopause.

  2023cites this paper
• Guideline No. 443a: Opioid Use Throughout Women's Lifespan: Fertility, Contraception, Chronic Pain, and Menopause.

  2023cites this paper
• Opioid and benzodiazepine utilization patterns in metropolitan and rural Texas.

  2023cites this paper
• Prescription high-risk polysubstance use among opioid maintenance treatment patients.

  2023cites this paper
• Oral buprenorphine utilization, concomitant benzodiazepines and opioid analgesics, and payment source: Trends from 2015 to 2019.

  2023cites this paper
• Oxidative Stress in Substance Use Disorders: Endogenous and Exogenous Mechanisms of Repair

  2023cites this paper
• Hydrocodone, Oxycodone, and Morphine Metabolism and Drug–Drug Interactions

  2023cites this paper
• Co-prescribing of Opioids and Psychotropic Medications Among Medicare-enrolled Older Adults on Long-term Opioid Therapy.

  2023cites this paper
• Understanding the rise in overdose deaths involving opioids and non-opioid prescription drugs in the United States.

  2023cites this paper
• Substance Use Disorders in the Geriatric Population: a Review and Synthesis of the Literature of a Growing Problem in a Growing Population

  2023cites this paper
• Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020.

  2023cites this paper
• Drug-Related Problems and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study

  2022cites this paper
• An observational study of the factors associated with frequency of outpatient benzodiazepine prescribing to patients receiving chronic opioid analgesic therapy in primary care at a major academic center

  2022cites this paper
• The immediate and long-term effects of prenatal opioid exposure

  2022cites this paper
• Buprenorphine treatment episode duration, dosage, and concurrent prescribing of benzodiazepines and opioid analgesics: The effects of Medicaid prior authorization policies.

  2022cites this paper
• Benzodiazepines and Related Drugs in Orthopaedics

  2022cites this paper
• Clarifying CDC’s Efforts to Quantify Overdose Deaths

  2022cites this paper
• Population-based screening to detect benzodiazepine drug-drug-drug interaction signals associated with unintentional traumatic injury

  2022cites this paper
• Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects

  2022cites this paper
• Epidemiology of opioid use in pregnancy.

  2022cites this paper
• Trends in Concurrent Opioid and Benzodiazepine Prescriptions in the United States, 2016 to 2019

  2022cites this paper
• Trends in Prescribing Opioids, Benzodiazepines, and Both Among Adults with Alcohol Use Disorder in New York State

  2022cites this paper
• Differences in buprenorphine treatment quality across physician provider specialties.

  2022cites this paper
• Sociodemographic Differences in Quality of Treatment to Medicaid Enrollees Receiving Buprenorphine

  2022cites this paper
• Early detection of patients with narcotic use disorder using a modified MEDD score based on the analysis of real-world prescription patterns

  2022cites this paper
• Opioid and benzodiazepine substitutes: Impact on drug overdose mortality in Medicare population.

  2022cites this paper
• A descriptive analysis of concomitant opioid and benzodiazepine medication use and associated adverse drug events in United States adults between 2009 and 2018

  2022cites this paper
• Evaluating opioid analgesic prescribing limits: A narrative review

  2022cites this paper
• Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: Group-based multi-trajectory models.

  2022cites this paper
• Diagnostic and Predictive Capacity of the Spanish Versions of the Opioid Risk Tool and the Screener and Opioid Assessment for Patients with Pain—Revised: A Preliminary Investigation in a Sample of People with Noncancer Chronic Pain

  2022cites this paper
• Oxycodone-Related Deaths: The Significance of Pharmacokinetic and Pharmacodynamic Drug Interactions

  2022cites this paper
• Benzodiazepines and Related Sedatives.

  2022cites this paper
• The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic.

  2021cites this paper
• Women, opioid use and addiction

  2021cites this paper
• Concurrent Use of Prescription Opioids and Gabapentinoids in Older Adults.

  2021cites this paper
• Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States

  2021cites this paper
• What Your Death Certificate Says About You May Be Wrong: A Narrative Review on CDC’s Efforts to Quantify Prescription Opioid Overdose Deaths

  2021cites this paper
• Toxicological and pharmacologic sex differences in unintentional or undetermined opioid overdose death.

  2021cites this paper
• Risk of fall‐related injury and all‐cause hospitalization of select concomitant central nervous system medication prescribing in older adult persistent opioid users: A case‐time‐control analysis

  2021cites this paper
• Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review.

  2021cites this paper
• Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study

  2021cites this paper
• Association Between Benzodiazepine and Opioid Prescription and Mortality Among Patients in a Large Healthcare System

  2021cites this paper
• New Persistent Opioid and Benzodiazepine Use After Curative-Intent Treatment in Patients With Breast Cancer.

  2021cites this paper
• Association of New Perioperative Benzodiazepine Use With Persistent Benzodiazepine Use

  2021cites this paper
• A Novel Maintenance Therapeutic for Opioid Use Disorder

  2021cites this paper
• Relation between preoperative benzodiazepines and opioids on outcomes after total joint arthroplasty

  2021cites this paper
• Benzodiazepine exposures among women of reproductive age in the US, 2004–2018

  2021cites this paper
• Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data

  2021cites this paper
• Concomitant inpatient prescribing of strong opioids with sedatives: Associations with comorbid conditions

  2021cites this paper
• A high-throughput bioanalytical assay to support pharmacokinetic interaction study of oxycodone and diazepam in Sprague Dawley rats

  2020cites this paper
• Child and adolescent benzodiazepine exposure and overdose in the United States: 16 years of poison center data

  2020cites this paper
• Gender differences in diversion among non-medical users of prescription opioids and sedatives

  2020cites this paper
• The effect of an opioid prescription days' supply limit on patients receiving long-term opioid treatment.

  2020cites this paper
• Effects of oxycodone and diazepam alone and in combination on operant nociception

  2020cites this paper
• Developing an animal model to detect drug–drug interactions impacting drug-induced respiratory depression

  2020cites this paper
• Public Perceptions of Risks Associated with Mixing Opioid Pain-Relievers with Alcohol and Benzodiazepines

  2020cites this paper
• Emergency Department Visits Attributed to Adverse Events Involving Benzodiazepines, 2016-2017.

  2020cites this paper
• Preliminary Investigation of Pharmacist-Delivered, Direct-to-Provider Interventions to Reduce Co-Prescribing of Opioids and Benzodiazepines among a Medicare Population

  2020cites this paper
• Co-prescribing of Opioids with Benzodiazepines and Other Hypnotics for Chronic Pain and Insomnia: Trends and Health Outcomes.

  2020cites this paper
• Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease

  2020cites this paper
• Opioid-Prescribing Metrics in Washington State: Trends and Challenges

  2020cites this paper
• Association Between Community Characteristics and Opioid Prescribing Rates

  2020cites this paper
• Limited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review

  2020cites this paper
• Mortality Following Nonfatal Opioid and Sedative/Hypnotic Drug Overdose.

  2020cites this paper
• Co-occurring opioid and sedative use disorder: Gender differences in use patterns and psychiatric co-morbidities in the United States.

  2020cites this paper
• Patterns and characteristics of polypharmacy among elderly residents in Danish nursing homes

  2020cites this paper
• Design, synthesis and neuropharmacological evaluation of new 2,4-disubstituted-1,5-benzodiazepines as CNS active agents.

  2020cites this paper
• Potentially Inappropriate Medication Combination with Opioids among Older Dental Patients: A Retrospective Review of Insurance Claims Data

  2020cites this paper
• CHRONIC OPIOID THERAPY: A SCOPING LITERATURE REVIEW ON EVOLVING CLINICAL AND SCIENTIFIC DEFINITIONS.

  2020cites this paper
• Assessment of Co-Occurring Substance Use During Opiate Treatment Programs in the United States.

  2020cites this paper
• Predictive Modeling of Long-Term Opioid and Benzodiazepine Use after Intradural Tumor Resection.

  2020cites this paper
• Challenges for Women Entering Treatment for Opioid Use Disorder

  2020cites this paper
• Prevalence of Concurrent Use of Prescribed Opioids and Benzodiazepine/Z-drugs and its Effect on Adverse Outcomes in Alberta

  2020influential citation
• Trends in Co-Prescribing of Opioids and Opioid Potentiators Among U.S. Adults, 2007-2018.

  2020cites this paper
• Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study

  2020cites this paper
• Fifty Years of Research on Prenatal Substances: Lessons Learned for the Opioid Epidemic

  2020cites this paper
• Enhanced recovery after surgery (ERAS) in clinical practice

  2020cites this paper
• Benzodiazepines use in Morocco: A nation wide consumption database study between 2004 and 2017.

  2019cites this paper
• U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016.

  2019cites this paper
• Postoperative pain and analgesic requirements after septoplasty and rhinoplasty

  2019cites this paper
• Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016.

  2019cites this paper
• Patterns in Outpatient Benzodiazepine Prescribing in the United States

  2019cites this paper
• Tramadol Prescription over a 4-Year Period in the USA

  2019cites this paper
• Benzodiazepine and opioid co-usage in the US population, 1999–2014: an exploratory analysis

  2019cites this paper